WEST PALM BEACH, Fla., March 28, 2016 (GLOBE NEWSWIRE) -- Regenerative Medicine Foundation (RMF) the producer of the annual World Stem Cell Summit & RegMed Capital Conference, announced the event is returning to West Palm Beach at the Palm Beach County Convention Center for its 12th annual meeting on December 6-9, 2016. The announcement was made at a life science-focused public meeting organized by the Business Development Board of Palm Beach County.
The Summit is the largest interdisciplinary stem cell meeting in the world, featuring more than 250 prominent scientists, business leaders, investors, philanthropists, regulators, policy-makers, economic development officers, patient advocates and experts in law and ethics, presenting the latest scientific discoveries, commercial and innovation opportunities, legal and regulatory solutions, and best practices. The event is expected to attract more than 1,200 attendees from 40 nations.
Held last year in Atlanta, this year marks the first time the World Stem Cell Summit will make a return to a previous event location, The Palm Beaches. The World Stem Cell Summit was first held in West Palm Beach in 2012, and returns to the same city this year. The 2016 Summit will include a completely updated program. New features include the RegMed Capital Conference (RMCC), providing attendees a complete 360-degree view of the Regenerative Medicine industry, stem cell science, clinical trials and regulation for an audience of investment banks, venture funds and individual investors; a custom event platform and mobile app allowing attendees to identify people they want to meet, ask for a meeting and have it automatically fit into their schedules; and new sessions showcasing astonishing advances in equine regenerative medicine with implications for the betterment of human health. The Palm Beach International Equestrian Center (PBIEC), located in Wellington, is considered the most recognizable equestrian sporting venue in America. Finally, WSCS16 will include a Public Education Day, free and open to the community with interactive workshops for students and adults.
RMF Executive Director Bernard Siegel, founder and co-chair of the Summit said, "We are delighted to return to West Palm Beach for the 2016 World Stem Cell Summit & RegMed Capital Conference. The State of Florida has emerged as a leader in healthcare and bioscience. Prominent local associations and regional institutions have expressed their support of the international regenerative medicine community's foremost event. Additionally, Summit attendees will enjoy the hospitality of one of the premier resort destinations on the planet. It is a testament to The Palm Beaches that for the first time in the event's history, the Summit returns to the same location. The area is rated a top conference venue by our past Summit attendees, who praised the regional amenities, hospitality and 'gem' of a convention center."
Kelly L. Smallridge, President and CEO of the Business Development Board of Palm Beach County (BDB), Palm Beach County's public/private economic development agency, remarked, "The Regenerative Medicine Foundation's decision to return to Palm Beach County validates the regional investment in biotech infrastructure. With the addition of the RegMed Capital Conference to the program, the Summit will showcase Palm Beach County to the world. Investors and companies looking to expand or relocate will see firsthand that Palm Beach County has the best business climate in the State of Florida. The Summit will again provide revenue and overall positive economic impact to our area. We are thrilled to welcome home the global regenerative medicine community in 2016."
"Over the past decade, Florida has built a robust life sciences industry with stem cell research and novel regenerative medicine technology now emerging as a key area of strength for the state," said Nancy K. Bryan, president & CEO of BioFlorida, Florida's statewide association supporting the life sciences. "We are thrilled that the World Stem Summit & RegMed Capital Conference is returning to Florida as this Conference will provide an opportunity for Florida universities, institutions and companies to highlight their expertise and to collaborate with thought leaders around the globe to drive continued innovation and growth."
"Hosting the World Stem Cell Summit showcases what The Palm Beaches can offer to the competitive groups and meetings industry," said Kelly Cavers, senior vice president of group sales for Discover The Palm Beaches, the official tourism marketing corporation for Palm Beach County. "This flagship meeting of the international stem cell community is a renowned gathering of global stakeholders. The event will create a buzz in the medical industry, and will help us entice future meetings as we build our reputation as a desirable destination in the meetings and conventions market. As the chosen destination for this event – not once, but twice – we are confident attendees will understand why The Palm Beaches are the best way to meet in Florida."
MORE ABOUT THE WORLD STEM CELL SUMMIT: The World Stem Cell Summit & RegMed Capital Conference is the established global meeting place for regenerative medicine leadership. Produced by the newly merged nonprofit Regenerative Medicine Foundation and Genetics Policy Institute and organized with leading academic and research institutions, the impactful 7-track Summit delivers an abundance of information and networking opportunities unavailable at any other meeting. The goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies, bringing global stakeholders together to solve global challenges. Visit www.worldstemcellsummit.com for more information.
For information about sponsoring the World Stem Cell Summit, contact Regenerative Medicine Foundation Associate Director, Alan Fernandez at (650) 847-1640 or Alan@genpol.org.
World Stem Cell Summit & RegMed Capital Conference Returns to West Palm Beach
International Regenerative Medicine Community to Convene for 12th Anniversary Summit in Florida, December 2016
| Source: Genetics Policy Institute